Loading organizations...
Loading organizations...
Biotechnology company developing nasal vaccines for swine viral diseases.
Aptimmune has raised $2.8M across 1 funding round.
Aptimmune has raised $2.8M in total across 1 funding round.
Aptimmune has raised $2.8M in total across 1 funding round.
Aptimmune's investors include Pete Reinecke, Fox Ventures.
Aptimmune has raised $2.8M across 1 funding round. Most recently, it raised $2.8M Series A in July 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 10, 2015 | $2.8M Series A | Pete Reinecke, Fox Ventures |